Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine
- PMID: 3382592
- PMCID: PMC1387813
- DOI: 10.1111/j.1365-2125.1988.tb03335.x
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine
Abstract
Debrisoquine (DQ) has no chiral centre, but hydroxylation in position 4 leads to formation of an asymmetric carbon centre with two possible enantiomers, their absolute configuration being R(-) and S(+)-4-hydroxydebrisoquine (4-OHDQ). Since the absolute stereochemistry of the 4-hydroxylation of DQ in man is unknown, the enantioselectivity of this process was studied in panels of extensive (EM) and poor metabolizers (PM) of DQ. In EM subjects 4-hydroxylation of DQ leads almost exclusively to the formation of S(+)-4-OHDQ. In contrast, PM subjects were not only characterized by a decreased total 4-OHDQ formation but also a marked loss of enantioselectivity in product formation. Between 5 to 36% of total 4-OHDQ was excreted as R(-)-4-OHDQ.
Similar articles
-
Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population.Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):7-10. Zhongguo Yao Li Xue Bao. 1990. PMID: 2403020
-
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment.Pharmacol Toxicol. 1987 Apr;60(4):312-4. doi: 10.1111/j.1600-0773.1987.tb01758.x. Pharmacol Toxicol. 1987. PMID: 3588528
-
Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.Br J Clin Pharmacol. 1988 Dec;26(6):791-5. doi: 10.1111/j.1365-2125.1988.tb05321.x. Br J Clin Pharmacol. 1988. PMID: 3242585 Free PMC article.
-
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
-
Inhibition of desipramine 2-hydroxylation by quinidine and quinine in rapid and slow debrisoquine hydroxylators.Psychopharmacol Ser. 1989;7:201-5. doi: 10.1007/978-3-642-74430-3_21. Psychopharmacol Ser. 1989. PMID: 2687858 Review. No abstract available.
Cited by
-
Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.Br J Clin Pharmacol. 1989 Nov;28(5):555-66. doi: 10.1111/j.1365-2125.1989.tb03542.x. Br J Clin Pharmacol. 1989. PMID: 2511912 Free PMC article.
-
Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.Clin Pharmacokinet. 1990 Mar;18(3):220-39. doi: 10.2165/00003088-199018030-00004. Clin Pharmacokinet. 1990. PMID: 2182263 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources